沃森生物：公司将进一步积极把握国家生物制造战略机遇

Core Viewpoint - Watson Bio (300142) emphasizes its commitment to innovation in the human vaccine sector, leveraging over 20 years of experience and aligning with national biomanufacturing strategies [1] Company Development - The company is focused on continuously expanding its product pipeline by actively monitoring advancements in new technologies [1] - Watson Bio encourages stakeholders to refer to official announcements for updates on technology and product research and development progress [1]